| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.26 | 0.2 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-08 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.18 | 0.5 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-06 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.14 | 0.4 |